Treatment of chronic hepatitis C in HIV-positive individuals: Selection of candidates

Journal of Hepatology

Volumn 44, Issue SUPPL. 1, 2006, Pages

  Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Candidates; Hepatitis C; HIV; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; RIBAVIRIN; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; CD4 LYMPHOCYTE COUNT; CONFERENCE PAPER; DRUG DEPENDENCE; GENOTYPE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER FIBROSIS; PATIENT COMPLIANCE; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION;

ANTIVIRAL AGENTS; DISEASE PROGRESSION; HEPATITIS C, CHRONIC; HIV; HIV INFECTIONS; HUMANS; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 30144435322     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.11.032     Document Type: Conference Paper

References (38)

1. V. Soriano, M. Puoti, M. Sulkowski, S. Mauss, P. Cacoub, and A. Cargnel Care of patients with hepatitis C and HIV co-infection: updated recommendations from the HIV-HCV International Panel AIDS 17 2004 1 12
2. J.K. Rockstroh, A. Mocroft, V. Soriano, C. Tural, M.H. Losso, and A. Horban Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy J Infect Dis 192 2005 992 1002
3. L. Martín-Carbonero, Y. Benhamou, M. Puoti, J. Berenguer, J. Mallolas, and C. Quereda Incidence and predictors of severe liver fibrosis in HIV-infected patients with chronic hepatitis C: a European collaborative study Clin Infect Dis 38 2004 128 133
4. M. Puoti, R. Bruno, V. Soriano, F. Donato, G. Gaeta, and G. Quinzan Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome AIDS 18 2004 2285 2293
5. M. Nuñez, and V. Soriano Hepatotoxicity of antiretrovirals: incidence, mechanisms and management Drug Saf 28 2005 53 66
6. C. Fleming, D. Craven, D. Thorton, S. Tumilty, and S. Nunes Hepatitis C virus and HIV co-infection in an urban population: low eligibility for interferon treatment Clin Infect Dis 36 2003 97 100
7. A. Rauch, M. Egger, J. Reichen, H. Furrer, and Swiss HIV Cohort Study Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin J Acq Immun Def Syn 38 2005 238 240
8. S. Fultz, A. Justice, A. Butt, L. Rabeneck, S. Weissman, M. Rodriguez-Barradas, and for the VACS-3 project team Testing, referral, and treatment patterns for hepatitis C virus co-infection in a cohort of veterans with HIV infection Clin Infect Dis 36 2003 1039 1046
9. C. Hall, E. Charlebois, J. Hahn, A. Moss, and D. Bangsberg Hepatitis C virus infection in San Francisco's HIV-infected urban poor J Gen Intern Med 19 2004 357 365
10. L. Martín-Carbonero, V. Soriano, E. Valencia, J. García-Samaniego, M. López, and J. González-Lahoz Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients AIDS Res Hum Retroviruses 17 2001 1467 1471
11. M. Puoti, A. Spinetti, A. Ghezzi, and G. Carosi Mortality for liver disease in patients with HIV-infection: a cohort study J Acquir Immun Defic Syndr 24 2000 211 217
12. E. Rosenthal, M. Poiree, C. Pradier, C. Perronne, D. Salmon-Ceron, and L. Geffray Mortality due to hepatitis C related liver disease in HIV-infected patients in France (Mortavic 2001 study) AIDS 17 2003 1803 1809
13. I. Bica, B. McGovern, R. Dhar, D. Stone, K. McGowan, and R. Scheib Increasing mortality due to end-stage liver disease in patients with HIV infection Clin Infect Dis 32 2001 492 497
14. Sanchez-Somolinos M, Martin-Carbonero L, Valencia E, Nuñez MJ, Garcia-Samaniego J, Soriano V. Reduction in liver-related hospital admissions and deaths in HIV+ patients since year 2001. Third international AIDS conference on HIV pathogenesis & treatment, Rio de Janeiro; Abstract 286.
15. N. Brau Treatment of chronic hepatitis C in HIV/hepatitis C virus-co-infected patients in the era of pegylated interferon and ribavirin Semin Liver Dis 25 2005 33 51
16. S. Mauss, H. Klinker, A. Ulmer, R. Willers, B. Weissbrich, and H. Albrecht Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with higher CD4+ cell count Infection 26 1998 16 19
17. V. Soriano, J. Garcia-Samaniego, R. Bravo, J. Gonzalez, A. Castro, and J. Castilla Interferon alpha for the treatment of chronic hepatitis C in patients infected with HIV. Hepatitis-HIV Spanish Study Group Clin Infect Dis 23 1996 585 591
18. F. Torriani, M. Rodríguez-Torres, J. Rockstroh, E. Lissen, J. Gonzalez-Garcia, and A. Lazzarin Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450
19. S. Vento, G. Di Perri, M. Cruciani, T. Garofano, E. Concia, and D. Bassetti Rapid decline of CD4+ cells after interferon treatment in HIV-1 infection Lancet 341 1993 958 959
20. A. Pesce, B. Taillan, and E. Rosenthal Opportunistic infections and CD4 lymphocytopenia with interferon treatment in HIV-1 infected patients Lancet 341 1993 1597
21. M. Ziol, A. Handra-Luca, A. Kettaneh, C. Christidis, F. Mal, and F. Kazemi Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Hepatology 41 2005 48 54
22. L. Castera, J. Vergniol, J. Foucher, B. Le Bail, E. Chanteloup, and M. Haaser Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
23. R. Myers, Y. Benahamou, F. Imbert-Bismut, V. Thibault, M. Bochet, and F. Charlotte Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients AIDS 17 2003 721 725
24. Sterling R, Lissen E, Clumeck N, Sola R, Correa M, Montaner J, et al. Can routine non-invasive tests predict liver histology in HIV/HCV co-infection? Analysis of patients entering the APRICOT. 12th CROI, Boston; Feb 2005 [abstract 120].
25. X. Forns, M. Garcia-Retortillo, T. Serrano, A. Feliu, F. Suarez, and M. de la Mata Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation J Hepatol 39 2003 389 396
26. A. Lafeuillade, G. Hittinger, and S. Chapadaud Increased mitochondrial toxicity with ribavirin in HIV/HCV co-infection Lancet 357 2001 280 281
27. A. Moreno, C. Quereda, L. Moreno, M.J. Perez-Elias, A. Muriel, and J.L. Casado High rate of didanosine-related mitochondrial toxicity in HIV/HCV-co-infected patients receiving ribavirin Antiviral Ther 9 2004 133 138
28. S. Mauss, W. Valenti, J. de Pamphilis, F. Duff, L. Cupelli, and S. Passe Risk factors for hepatic decompensation in patients with HIV-HCV co-infection and liver cirrhosis during interferon-based therapy AIDS 18 2004 F21 F25
29. M. Laguno, J. Blanch, J. Murillas, J.L. Blanco, A. Leon, and M. Lonca Depressive symptoms after initiation of interferon therapy in HIV-infected patients with chronic hepatitis C Antiviral Ther 9 2004 905 909
30. T. García-Benayas, F. Blanco, and V. Soriano Weight loss in HIV-infected patients N Engl J Med 347 2002 1287 1288
31. Nuñez M, Maida I, Berdun MA, Soriano V, on behalf of the PRESCO Team. Efficacy and safety of pegylated interferon alpha-2a plus ribavirin for the treatment of chronic hepatitis C in HIV-co-infected patients: the PRESCO trial. 44th ICAAC, Washington DC; November 2004 [abstract V-1148].
32. M. Pérez-Olmeda, M. Núñez, M. Romero, J. Gonzalez, J. Arribas, and V. Soriano Pegylated interferon alpha 2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients AIDS 17 2003 1023 1028
33. R. Chung, J. Andersen, P. Volberding, G.K. Robbins, T. Liu, and K. Sherman Peginterferon alfa-2a plus ribavirin vs interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-co-infected persons N Engl J Med 351 2004 451 459
34. F. Carrat, F. Bani-Sadr, S. Pol, E. Rosenthal, F. Lunel-Fabiani, and A. Benzekri Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients J Am Med Assoc 292 2004 2839 2848
35. M. Laguno, J. Murillas, J.L. Blanco, E. Martinez, R. Miquel, and J.M. Sanchez-Tapias Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients AIDS 18 2004 F27 F36
36. V. Soriano, M. Nuñez, N. Camino, I. Maida, P. Barreiro, and M. Romero Hepatitis C virus-RNA clearance in HIV-co-infected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin Antivir Ther 9 2004 505 509
37. V. Soriano, L. Martín-Carbonero, and J. García-Samaniego Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis? AIDS 17 2003 751 753
38. F. Kuehne, U. Bethe, K. Freedberg, and S. Goldie Treatment for hepatitis C virus in HIV-infected patients: clinical benefits and cost-effectiveness Arch Intern Med 162 2002 2545 2556